Modeling & Simulation Cases
PBPK-DDI Model for DDI Clinical Study Exemption
With data of strong CYP inhibitors/inducers, PBPK-DDI simulation predicts DDI risk of moderate/weak modulators, which can be used to apply for exemption of dedicated clinical DDI trials.
